Luigi Spagnoli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Luigi Spagnoli has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Andrea Cavazzana
U.O.C. Anatomia Patologica Carrara, Azienda Sanitaria Toscana Nord Ovest, Carrara, Italy
3 shared publications- Federica Petrelli
USL Northwest Tuscany, “Monterosso” Polyspecialistic Center, Pathology Unit
3 shared publications - Maria Raffaella Ambrosio
Department of Pharmacy, Health and Nutrition Sciences, University of Calabria, 87036 Cosenza, Italy
3 shared publications - Bruno Perotti
General Surgery Unit, Versilia Hospital – AUSL Toscana Nord-Ovest
2 shared publications - Luigi Marano
Department of Surgery, Dnipro State Medical University, Dnipro, Ukraine
2 shared publications - Marco Arganini
Department of Surgery, Versilia Hospital of Viareggio, 55049 Camaiore, Italy
2 shared publications
Latest Publications
- 1 July 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Medical Robotics and Bionics
- Vol. 6 (3) , 888-902
Technologies for the Automation of Anatomic Pathology Processes: A Review
One of the primary roles of an anatomic pathology laboratory (APL) is the identification of tissue abnormalities, which is crucial for diagnosing diseases and defining a suitable therapy. To date, a considerable number of human errors and artifacts affect the APL test cycle in all its phases (pre-analytical, intra-analytical, analytical, and post-analytical), mainly due to manual and non-standardized procedures. An extensive use of technologies (among which robotic ones) aimed at favoring laboratory automation procedures, would be key in decreasing these errors and their clinical consequences. However, several improvements in workflow, technology and standardization still need to occur. In this review, we discuss the current level of automation currently available in the APL histopathologic production workflow in all phases of the test cycle, highlighting the legal and ethical issues related to their adoption.
- 1 July 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Medical Robotics and Bionics
- Vol. 6 (3) , 888-902
Technologies for the Automation of Anatomic Pathology Processes: A Review
One of the primary roles of an anatomic pathology laboratory (APL) is the identification of tissue abnormalities, which is crucial for diagnosing diseases and defining a suitable therapy. To date, a considerable number of human errors and artifacts affect the APL test cycle in all its phases (pre-analytical, intra-analytical, analytical, and post-analytical), mainly due to manual and non-standardized procedures. An extensive use of technologies (among which robotic ones) aimed at favoring laboratory automation procedures, would be key in decreasing these errors and their clinical consequences. However, several improvements in workflow, technology and standardization still need to occur. In this review, we discuss the current level of automation currently available in the APL histopathologic production workflow in all phases of the test cycle, highlighting the legal and ethical issues related to their adoption.
- Open Access
Immunohistochemical Markers of the Epithelial-to-Mesenchymal Transition (EMT) Are Related to Extensive Lymph Nodal Spread, Peritoneal Dissemination, and Poor Prognosis in the Microsatellite-Stable Diffuse Histotype of Gastric Cancer
Background: Although the prognostic value of the epithelial-to-mesenchymal transition (EMT) in gastric cancer has been reported in several studies, the strong association with the diffuse type may represent a confounding factor. Our aim is to investigate potential correlations among EMT status, tumor advancement, and prognosis in diffuse gastric cancer. Methods: Between 1997 and 2012, 84 patients with microsatellite-stable (MSS) diffuse-type tumors underwent surgery. The EMT phenotype was assessed with the E-cadherin, CD44, and zinc finger E-box binding homeobox 1 (ZEB-1) immunohistochemical markers. Results: Forty-five out of 84 cases (54%) were EMT-positive; more advanced nodal status (p = 0.010), pTNM stage (p = 0.032), and vascular invasion (p = 0.037) were observed in this group. The median numbers of positive nodes (13 vs. 5) and involved nodal stations (4 vs. 2) were higher in the EMT-positive group. The cancer-related survival time was 26 months in EMT-positive cases vs. 51 in negative cases, with five-year survival rates of 17% vs. 51%, respectively (p = 0.001). The EMT status had an impact on the prognosis of patients with <70 years, R0 resections, or treatment with adjuvant chemotherapy. Tumor relapses after surgery and peritoneal spread were significantly higher in the EMT-positive tumors. Conclusions: EMT status, when assessed through immunohistochemistry, identified an aggressive phenotype of MSS diffuse-type tumors with extensive lymph nodal spread, peritoneal dissemination, and worse long-term outcomes.
Open AccessImmunohistochemical Markers of the Epithelial-to-Mesenchymal Transition (EMT) Are Related to Extensive Lymph Nodal Spread, Peritoneal Dissemination, and Poor Prognosis in the Microsatellite-Stable Diffuse Histotype of Gastric Cancer
Background: Although the prognostic value of the epithelial-to-mesenchymal transition (EMT) in gastric cancer has been reported in several studies, the strong association with the diffuse type may represent a confounding factor. Our aim is to investigate potential correlations among EMT status, tumor advancement, and prognosis in diffuse gastric cancer. Methods: Between 1997 and 2012, 84 patients with microsatellite-stable (MSS) diffuse-type tumors underwent surgery. The EMT phenotype was assessed with the E-cadherin, CD44, and zinc finger E-box binding homeobox 1 (ZEB-1) immunohistochemical markers. Results: Forty-five out of 84 cases (54%) were EMT-positive; more advanced nodal status (p = 0.010), pTNM stage (p = 0.032), and vascular invasion (p = 0.037) were observed in this group. The median numbers of positive nodes (13 vs. 5) and involved nodal stations (4 vs. 2) were higher in the EMT-positive group. The cancer-related survival time was 26 months in EMT-positive cases vs. 51 in negative cases, with five-year survival rates of 17% vs. 51%, respectively (p = 0.001). The EMT status had an impact on the prognosis of patients with <70 years, R0 resections, or treatment with adjuvant chemotherapy. Tumor relapses after surgery and peritoneal spread were significantly higher in the EMT-positive tumors. Conclusions: EMT status, when assessed through immunohistochemistry, identified an aggressive phenotype of MSS diffuse-type tumors with extensive lymph nodal spread, peritoneal dissemination, and worse long-term outcomes.
- 27 April 2022
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (2) , 313-321
Comparison of Survival Analysis After Surgery for Colorectal Cancer in Above 80 Years (Oldest-Old) and Below 80 Years Old Patients
- 27 April 2022
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (2) , 313-321
Comparison of Survival Analysis After Surgery for Colorectal Cancer in Above 80 Years (Oldest-Old) and Below 80 Years Old Patients
- 1 June 2021
- Published by Elsevier in Digestive and Liver Disease
- Vol. 53 (6) , 796-798
Jejunal gastrointestinal stromal tumor with rectal lymph nodes metastases synchronous to intestinal adenocarcinoma: a possible common origin
- 1 June 2021
- Published by Elsevier in Digestive and Liver Disease
- Vol. 53 (6) , 796-798
Jejunal gastrointestinal stromal tumor with rectal lymph nodes metastases synchronous to intestinal adenocarcinoma: a possible common origin
- 1 August 2020
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 38, 153-159
Preoperative oral immunonutrition in gastrointestinal surgical patients: How the tumour microenvironment can be modified
- 1 August 2020
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 38, 153-159
Preoperative oral immunonutrition in gastrointestinal surgical patients: How the tumour microenvironment can be modified
- Open Access
- 15 October 2019
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 5 (4) , 00157-2019
Occult malignancy underlying a case of “hyperacute” onset of severe pulmonary hypertension
Investigations in a patient with new-onset pulmonary hypertension should include screening for undiagnosed malignancyhttp://bit.ly/2mrLmGM
- 15 October 2019
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 5 (4) , 00157-2019
Open AccessOccult malignancy underlying a case of “hyperacute” onset of severe pulmonary hypertension
Investigations in a patient with new-onset pulmonary hypertension should include screening for undiagnosed malignancyhttp://bit.ly/2mrLmGM
- Open Access
- 14 July 2019
- Published by Wiley in Case Reports in Pathology
- Vol. 2019, 1-2
Lipomatous Hypertrophy: An Accidental Finding in Heart
Lipomatous hypertrophy is an uncommon benign lesion of the atrium, generally asymptomatic, characterized by unencapsulated accumulation of adipose tissue entrapping cardiomyocytes. This pathology generally remains unnoticed and often emerges as an occasional finding. Here, we report two cases from our hospital including a review of the available literature.
- 14 July 2019
- Published by Wiley in Case Reports in Pathology
- Vol. 2019, 1-2
Open AccessLipomatous Hypertrophy: An Accidental Finding in Heart
Lipomatous hypertrophy is an uncommon benign lesion of the atrium, generally asymptomatic, characterized by unencapsulated accumulation of adipose tissue entrapping cardiomyocytes. This pathology generally remains unnoticed and often emerges as an occasional finding. Here, we report two cases from our hospital including a review of the available literature.